Roles
- Professor
- Chief, Division of Cardiovascular Medicine
-
Biography
Yiannis S. Chatzizisis, MD, PhD is Professor of Cardiology, and Chief of the Cardiovascular Division at the Miller School of Medicine, University of Miami. He was trained in interventional cardiology and advanced non-invasive cardiovascular imaging at the Brigham and Women’s Hospital. His translational and clinical research is actively funded by the NIH, industry, and philanthropy (collectively $6 million over the last 6 years). He has authored more than 170 manuscripts published in Circulation, JACC, ATVB, Cardiovascular Research and Atherosclerosis among other journals. His research has received over 8,500 citations with an H-index of 43. He has received more than 40 international and national awards, including awards by the European Society of Cardiology, European Atherosclerosis Society, American Heart Association and Academy of Athens. In 2021 he received the “Bifurcation Person of the Year” award by the European Bifurcation Club. He serves as Associate Editor for Atherosclerosis, and Pharmacology and Therapeutics, and as manuscript reviewer for JACC and Circulation family journals among others. He is member NIH and DOD study sections. He serves as industry advisory board member and consultant on coronary stents, intracoronary imaging, and physiology. He is Fellow of ACC, AHA, SCAI and ESC, Member of the Board of Directors of the European Bifurcation Club and founding Member of the SCAI Bifurcation Club. Over the years, he has mentored many general cardiology, interventional cardiology, imaging and research fellows and faculty, who are now independent investigators, faculty, or trainees in renowned institutions in the U.S. and Europe. -
Education & Training
Education
Post Graduate Training
-
Honors & Awards
-
Research Interests
Clinical and research interests focus on complex coronary interventions with emphasis on bifurcations and mechanical circulatory support, invasive imaging, advanced non-invasive cardiovascular imaging, computational cardiovascular simulations, and mechanobiology of atherosclerosis. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 4 clinical trials.
-
The objective of the Gamefilm Registry is to collect observational data about the prevalence of CAD in NFL, NHL and NBA alumni.
- Principal Investigator: Ioannis Chatzizisis
- Study Phase: TBD
- Enrollment Status: Open
-
The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB to support market release in the United States and Japan. In the ISR Cohort this will be accomplished by randomizing subjects to either a Prevail DCB arm or an Agent DCB arm to compare results of the treatment of ISR with coronary lesions previously treated with DES or BMS in native coronary arteries. In the DNSV Cohort this will be accomplished through collection of data to compare results of the Prevail DCB to a DES historical control in subjects undergoing PCI for de novo lesions in small vessel disease.
- Principal Investigator: Ioannis Chatzizisis
- Study Phase: TBD
- Enrollment Status: Open
-
The purpose of this study is to evaluate the clinical safety of FFRangio guided study treatment compared with standard pressure wire-guided treatment in subjects with coronary artery disease being evaluated for percutaneous coronary intervention.
- Principal Investigator: Ioannis Chatzizisis
- Study Phase: Other
- Enrollment Status: Closed
-
The objective of the Global GPS Registry, including the US arm of the Global Paradise System Post Approval Study (US GPS), is to evaluate the real-world use of the Paradise System as per approved labeling. In addition, US GPS will collect data in patient populations underrepresented within the RADIANCE clinical program.
- Principal Investigator: Ioannis Chatzizisis
- Study Phase: Other
- Enrollment Status: Open
